Elvitegravir%2C Cobicistat%2C Emtricitabine%2C And Tenofovir Alafenamide + Simvastatin Interaction
Contraindicatedinteraction on record
Description
Lipid-modifying Agents: HMG-CoA Reductase Inhibitors: lovastatin simvastatin ↑ lovastatin ↑ simvastatin Coadministration with lovastatin or simvastatin is contraindicated due to potential for serious reactions such as myopathy including rhabdomyolysis.
Source: FDA drug label - elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide